Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-06-30

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Venous thromboembolic (VTE) disease is the first cause of maternal mortality in the world. Some other pregnancy pathologies called Placental Vascular Pathologies (PVP) are linked to VTE by biological thrombophilia and are the principal cause of perinatal mortality. the identification of predictive factors of risk of occurrence or recurrence of two pathologies could enable us to propose an appropriate monitoring of patients at risk.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Evaluation of the Pathophysiology of Varicose Veins in Pregnancy

NCT05058989

Varicose Veins Varicose Veins of Lower Limb Chronic Venous Insufficiency +1 more

COMPLETED

Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients

NCT02697123

Venous Thrombosis Pregnancy

TERMINATED

Whole-leg Ultrasound in Pregnant Patients

NCT01319474

Deep Vein Thrombosis

UNKNOWN NA

Pelvic Embolisation to Reduce Recurrent Varicose Veins - Primary

NCT01901731

Varicose Veins Venous Reflux

UNKNOWN NA

Pelvic Embolisation to Reduce Recurrent Varicose Veins - Recurrent

NCT01909024

Varicose Veins Venous Reflux Pelvic Congestion Syndrome

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Main aim: To evaluate echographic, doppler and biological markers in a prospective manner as a potential predictive factor of risk of PVP and VTE.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Placental Vascular Pathologies Venous Thromboembolism Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

pregnancy women

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* previous history of one or more PVC episodes (preeclampsia, HELLPs, retroplacental hematoma, vascular IUGR\<10th percentile, recurrence miscarriage \>2, unexplained IUFD or IUFD after abruption placentae, eclampsia.
* Previous history of personal VTE
* Diabete (treated with diet or insulin)
* chronic hypertension
* chronic renal pathology
* lupus
* obesity
* Antihopholipids syndrome
* early and late pregnancy (\<18 years, \>38 years)
* family history of cardiovascular disease of VTE
* known biological thrombophilia without any personal past history of PVC or VTE

Exclusion Criteria

* Multiple pregnancy
* past history of in utero fetal death due to congenital malformations, rhesus incompatibility or an infection
* previous history of IUGR which etiology was a chromosomal, genic or infectious anomaly

Minimum Eligible Age

16 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No